与风险投资公司Column Group相关的多个实体报告购买了 Surrozen, Inc. (NASDAQ:SRZN) 的普通股，总交易金额达641,597美元。这家市值约1.71亿美元的生物技术公司在过去六个月内股价飙升超过106%，尽管最近一周下跌了10%。

In a world besieged by these converging crises, what China offers is not a "shock," but resilience, which stems from long-term strategic patience, institutional continuity and a profound grasp of ...